Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Completed
- Conditions
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Pierre Fabre Pharma AG
- Target Recruit Count
- 327
- Registration Number
- NCT04318405
- Locations
- 🇨🇭
8, Kreuzlingen, Switzerland
🇨🇭15, Biel, Switzerland
🇨🇭11, Kreuzlingen, Switzerland
© Copyright 2024. All Rights Reserved by MedPath